Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NDAC OTC switch presentations should resemble scientific society meetings -- Reidenberg.

This article was originally published in The Tan Sheet

Executive Summary

ADVISORY COMMITTEE Rx-TO-OTC SWITCH SPONSOR PRESENTATIONS should resemble scientific society presentations, Nonprescription Drugs Advisory Committee member Marcus Reidenberg, MD, suggested at a Feb. 17 Institute for International Research meeting on Rx-to-OTC switches in New York City. When appearing before the advisory committee, industry representatives should "give thoughtful, scientific presentations" as if they are "presenting it at a scientific society meeting, such as the American Heart [Association]," Reidenberg advised.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts